Immunocompromising Medications
Patients who are actively taking immune-suppressing or modulating medications on the following (alphabetized) list compiled by UConn Health physicians may be eligible for a third dose of COVID-19 vaccine.
Please note that this list is instructive, and not intended to be all-inclusive of medications that may suppress or modulate the immune system.
| Generic Name | Brand Name |
| 5-Fluorouracil | Carac |
| Abatacept | Orencia |
| Adalimumab | Humira |
| Alemtuzumab | Campath |
| Altretamine | Hexalen |
| Anakinra | Kineret |
| Atezolizumab | Tecentriq |
| Avelumab | Bavencio |
| Azathioprine | Imuran |
| Baricitinib | Olumiant |
| Basiliximab | Simulect |
| Belatacept | Nulojix |
| Bendamustine | Bendeka |
| Bevacizumab | Avastin |
| Busulfan | Myleran |
| Carmustine | Gliadal Wafer |
| Certolizumab pegol | Cimzia |
| Cetuximab | Erbitux |
| Chorambucil | Leukeran |
| Cisplatin | Platinol |
| cyclophosphamide | Nerosar |
| Cyclosporine | Gengraf, Neoral, Sandimmune |
| Cytarabine | Cytosar-U |
| Dacarbazine | |
| Dasatinib | Sprycel |
| Dexamethasone ≥ 3 mg | |
| Diaziquone | Progycem |
| Dimethyl fumarate | Tecfidera |
| Etanercept | Enbrel |
| Everolimus | Zortress |
| Fingolimod | Gilenya |
| Gemcitabine | |
| Glatiramer acetate | Copaxone |
| Golimumab | Simponi |
| Hydrocortisone ≥ 80 mg | |
| Hydroxychloroquine | Plaquenil |
| Ibritumomab tiuxetan | Zevalin |
| Ibrutinib | Imbruvica |
| ifosfamide | Ifex |
| Imatinib mesylate | Gleevec, STI 571 |
| Infliximab | Remicade |
| Interferon alfa | Pegasys, PegIntron |
| Interferon beta-1a | Avonex, Rebif |
| Interferon beta-1b | Betaseron |
| Ixekizumab | Taltz |
| Lenalidomide | Revlimid |
| Lomustine | Gleostine |
| Mechorethamine | Valchlor |
| Melphalan | Evomela |
| Mercaptopurine | Purinethol |
| Methotrexate | Otrexup, Trexall, Rasuvo |
| Methylprednisolone ≥ 16 mg | |
| Mitomycin C | |
| Mycophenolate | CellCept |
| Natalizumab | Tsabri |
| Nivolumab | Opdivo |
| Ofatumumab | Arzerra |
| Oxaliplatin | Eloxatin |
| Panitumumab | Vectibix |
| Pembrolizumab | Keytruda |
| Prednisolone ≥ 20 mg | |
| Premetrexed | |
| Procarbazine | Matulane |
| Rilonacept | Arcalyst |
| Rituximab | Rituxan |
| Sarilumab | Kevzara |
| Secukinumab | Cosentyx |
| Sirolimus | Rapamune |
| Streptozocin | Zanosar |
| Sunitinib malate | Sutent |
| Tacrolimus | Protopic, Envarsus XR |
| Temozolomide | Temodar |
| Thiotepa | Tepadina |
| Tocilizumab | Actemra |
| Tofacitinib | Xeljanz |
| Trastuzumab | Herceptin |
| Ustekinumab | Stelara |
| Vedolizumab | Entyvio |